Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Texas Capital Bancshares, a Texas-based financial services firm, announced it will move its primary stock listing from Nasdaq to the Texas Stock Exchange (TXSE) starting October 8, 2026, with a subsequent ticker symbol change from TCBI to TXCP effective November 9, 2026. The move underscores the company's commitment to its Texas roots and the state…
BriaCell Therapeutics announced that the independent Data Safety Monitoring Board (DSMB) has recommended continuing the company's pivotal Phase 3 trial of Bria-IMT combined with an immune checkpoint inhibitor for metastatic breast cancer. This marks the seventh consecutive positive DSMB review, indicating no safety concerns and reinforcing the favo…
Materion (MTRN) has been grinding higher off last year's low as demand for advanced electronic and aerospace materials recovers. Fundamentals and technicals suggest upside to near-term targets, and the risk/reward looks favorable if you accept a modestly elevated valuation. Trade plan provided for a long-term swing into $300 with a $245 stop.
Edible Garden AG Inc., a Nasdaq-listed leader in controlled environment agriculture and sustainable produce, is showcasing its expanding clean nutrition and ready-to-drink (RTD) products at the ECRM Vitamin, Weight Management & Sports Nutrition session. The company is promoting its Farm-to-Formula® strategy, leveraging its traditional produce busin…
Hub Group, Inc. released preliminary unaudited financial results for the first half of 2026, highlighting revenue in line with expectations but operating losses due to increased costs and accounting restatement-related expenses. The company is undergoing an extensive financial statement restatement process, which has delayed SEC filings and led Nas…
<p>Montage Gold (MAUTF) looks set to transition from developer to producer as a first gold pour approaches. The market has already priced in a lot of the story - market cap sits near $5.58B - but there is room for a meaningful swing if commissioning goes smoothly and early production beats modest expectations. This is a tactical long with a defined…
Stryker's stock has been punished this month, pushing the shares to a 52-week low near $267. Oversold technicals, a healthy balance sheet, and $4.7B of trailing free cash flow suggest a mean-reversion trade. We'll lay out an entry, stop and target for a mid-term swing (45 trading days) while highlighting the key operational and macro risks that cou…
Psyence Biomedical Ltd. (Nasdaq: PBM) announced the formation of Texas Ibogaine Research Corporation (TIRC) as a dedicated U.S.-based entity to coordinate the regulated development of pharmaceutical-grade ibogaine, including supply, regulatory engagement, and potential clinical trials. TIRC aims to hold U.S. rights to ibogaine developed by PsyLabs,…
Senseonics Holdings announces a strategic partnership with Beta Bionics to integrate its Eversense 365 year-long continuous glucose monitor with Beta Bionics' iLet Bionic Pancreas automated insulin delivery system. The collaboration aims to commercialize a combined diabetes management solution by Q4 2026, offering enhanced ease and autonomy to pati…
Corbus Pharmaceuticals announced positive topline data from its Phase 1b CANYON-1 study evaluating CRB-913 for obesity treatment. The oral CB1 inverse agonist showed statistically significant mean weight loss of 5% at 60 mg dosage after 12 weeks without weight loss plateau, and demonstrated a favorable safety and tolerability profile compared to or…
Macerich announced its participation in the BofA Securities 2026 Global Real Estate Conference, where its top executives will present and engage with investors, highlighting the company's position as a leading retail real estate investment trust with a substantial portfolio across key U.S. markets.
INmune Bio Inc. appointed R. Duane Clark II, a Sanofi rare-disease executive, and James Sapirstein, an experienced biopharma business development leader, to its Board of Directors. These appointments aim to bolster the company's commercialization planning for Ebstrocel™, a late-stage treatment targeting recessive dystrophic epidermolysis bullosa (R…
MediWound Ltd. announced that the independent Data and Safety Monitoring Board (DSMB) recommends continuing the Phase III VALUE study of EscharEx for venous leg ulcers without any modifications, following a safety review. The company expects to complete enrollment by Q1 2027, reinforcing confidence in the drug's favorable safety profile and ongoing…
Tilray Brands announced the opening of a new Hop Valley Brewing Co. pub in downtown Eugene, Oregon. The new location, opening September 17, aims to serve award-winning craft beers, including the popular Dang Green IPA, and feature a sports-focused atmosphere for Oregon Ducks fans, enhancing community engagement and brand presence in the region.
VisionWave Holdings, Inc. announced the filing of a U.S. non-provisional patent application describing ARGUS™, a proposed space-enabled, AI-driven counter-unmanned aircraft system (C-UAS) architecture. ARGUS integrates satellite surveillance, AI-based object recognition, resilient communications, and layered defensive technologies to detect and cou…
Lyell Immunopharma, a late-stage clinical company developing next-generation CAR T-cell therapies for cancer, will participate in the Baird 2026 Global Healthcare Conference. Senior management will discuss the company's clinical progress and manufacturing capabilities via a webcast. The company emphasizes its proprietary manufacturing center's capa…
Coda Octopus Group, Inc. reported a 9.2% increase in total revenue to approximately $7.7 million in fiscal Q3 2026, driven primarily by a 68.3% rise in its Defense Engineering Services segment. Despite geopolitical instability curbing Marine Technology sales, strong growth in defense services and acoustics sensors supported overall improved financi…
AirJoule Technologies Corporation has acquired BitSink, a U.S.-based company specializing in cooling and power distribution infrastructure for AI and high-performance computing data centers. This acquisition positions AirJoule as a broader infrastructure solutions provider, addressing critical constraints such as cooling, water, and power for next-…
Osisko Gold Group Inc. has officially approved the construction of its 100%-owned Cariboo Gold Project in British Columbia, targeting first gold production in Q1 2029 and commercial production by H2 2029. The project is supported by a $30 million strategic private placement and offtake agreements with Trafigura, along with a potential $120 million …
Ashland Inc. will host an Innovation Day webcast on September 17, 2026, where company leadership will present updated information on their innovative technology platforms, commercial progress, and scalability. The event aims to showcase advancements poised to impact key markets such as architectural coatings, construction, energy, food and beverage…
UMH Properties, Inc., a US-based REIT specializing in manufactured home communities, will present two innovative manufactured homes at the U.S. Department of Housing and Urban Development's annual Innovative Housing Showcase for the sixth year. The featured homes demonstrate advanced design and construction techniques enhancing affordable housing o…
GeNeuro, a US subsidiary of NRx Pharmaceuticals (Nasdaq: NRXP), announced the award of a European patent for GNK-301, a monoclonal antibody targeting the HERV K Envelope protein implicated in ALS. The patent complements two US patents and supports the technology to potentially modify ALS progression. GNK-301 manufacturing under cGMP is underway, wi…
Immunocore Holdings plc announced the successful enrollment of 540 patients in its registrational Phase 3 TEBE-AM trial assessing KIMMTRAK (tebentafusp) in previously treated patients with HLA-A*02:01-positive advanced melanoma. The trial evaluates KIMMTRAK as monotherapy and in combination with pembrolizumab against Investigator’s Choice, with ove…
Village Farms International has appointed Deepak Anand as Vice President of Government Affairs to lead global government relations and regulatory strategies. Anand's extensive experience in cannabis policy and international market development is expected to strengthen Village Farms' position and expansion in global cannabis markets. This strategic …
Pasithea Therapeutics announced it will present initial clinical data from Part A of its ongoing Phase 1/1b trial of PAS-004, a novel oral MEK inhibitor for neurofibromatosis type 1 (NF1)-associated neurofibromas, at the 2026 European Neurofibromatosis Conference in Vienna. This marks the company's first public disclosure of clinical data for the d…
